1,1-DIPHENYL-3-DIALKYLAMINO-1-SILACYCLOPENTANE DERIVATIVES - A NEW CLASS OF POTENT AND SELECTIVE 5-HT2A ANTAGONISTS

被引：14

作者：

DAMOUR, D

BARREAU, FM

DUTRUCROSSET, G

DOBLE, A

PIOT, O

MIGNANI, S

机构：

[1] RHONE-POULENC RORER S.A. Centre de Recherches de Vitry-Alfortville, 94403 Vitry-sur-Seine Cedex

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1994年 / 4卷 / 03期

关键词：

D O I：

10.1016/0960-894X(94)80007-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of 1,1-diphenyl-3-dialkylamino-1-silacyclopentanes was synthesized, and most compounds demonstrated moderate to high affinity for the 5-HT2A receptor. A member of this series, compound 1p displays potent antagonist activity after oral administration against both mescaline and DOI-induced head-twitches in mice and rats, with a long duration of action. The dextrorotatory isomer (+)-1p is highly more potent than the levorotatory isomer (-)-1p in in vitro and in in vivo assays.

引用

页码：415 / 420

页数：6

共 50 条

[31] New arylpiperazine derivatives with high affinity for α1A, D2 and 5-HT2A receptors
González-Gómez, JC
Santana, L
Uriarte, E
Brea, J
Villazón, M
Loza, MI
De Luca, M
Rivas, ME
Montenegro, GY
Fontenla, JA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) : 175 - 178
[32] Discovery of 5-arylsulfonamido-3(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists
Cole, DC
Lennox, WJ
Lombardi, S
Ellingboe, JW
Bernotas, RC
Tawa, GJ
Mazandarani, H
Smith, DL
Zhang, GM
Coupet, J
Schechter, LE
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 353 - 356
[33] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
Lee, TK
Robichaud, AJ
Boyle, KE
Lu, YM
Chen, WT
McClung, C
Deng, W
Miller, KJ
McElroy, JF
Largent, BL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
[34] Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists
Lasheras, B
Berjon, A
Montanes, R
Roca, J
Romero, G
Ramirez, MJ
DelRio, J
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1996, 46 (04): : 401 - 406
[35] New benzimidazole derivatives:: selective and orally active 5-HT3 receptor antagonists
Pascual, D
Girón, R
Alsasua, A
Benhamú, B
López-Rodríiguez, ML
Martín, MI
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 462 (1-3) : 99 - 107
[36] Design and synthesis of a new class of selective integrin α5β1 antagonists
Stragies, Roland
Osterkamp, Frank
Zischinsky, Gunther
Vossmeyer, Doerte
Kalkhof, Holger
Reimer, Ulf
Zahn, Grit
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (16) : 3786 - 3794
[37] 1,4-benzoxazin-3-(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands;: the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity
Mokrosz, MJ
Kowalski, P
Kowalska, T
Majka, Z
Duszynska, B
Charakchieva-Minol, S
Szaro, A
Tatarczynska, E
Klodzinska, A
Chojnacka-Wójcik, E
POLISH JOURNAL OF PHARMACOLOGY, 1998, 50 (4-5): : 333 - 340
[38] New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands
ElAhmad, Y
Laurent, E
Maillet, P
Talab, A
Teste, JF
Dokhan, R
Tran, G
Ollivier, R
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 952 - 960
[39] (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist
Franchini, Silvia
Tait, Annalisa
Prandi, Adolfo
Sorbi, Claudia
Gallesi, Rossella
Buccioni, Michela
Marucci, Gabriella
De Stefani, Carla
Cilia, Antonio
Brasili, Livio
CHEMMEDCHEM, 2009, 4 (02) : 196 - 203
[40] Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists
Ward, Simon E.
Eddershaw, Peter J.
Scott, Claire M.
Gordon, Laurie J.
Lovell, Peter J.
Moore, Susan H.
Smith, Paul W.
Starr, Kathryn R.
Thewlis, Kevin M.
Watson, Jeannette M.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) : 2887 - 2890

← 1 2 3 4 5 →